NASDAQ : COCP
Cocrystal Pharma, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.98 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 18.88M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Cocrystal Pharma, Inc. (COCP) reported revenue of 330.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 330.00K | |||||
| Cost of Revenue | 6.09M | 5.05M | 12.54M | 15.17M | 12.39M | 8.79M |
| Gross Profit | -5.76M | -5.05M | -12.54M | -15.17M | -12.39M | -8.79M |
| Selling, General & Admin | 4.35M | 3.96M | 5.34M | 5.99M | 5.75M | 5.43M |
| Operating Expenses | 4.35M | 3.96M | 5.34M | 5.99M | 5.75M | 5.43M |
| Operating Income | -10.11M | -9.02M | -17.88M | -21.16M | -18.14M | -14.22M |
| Interest Expense | -2.00K | -4.00K | ||||
| Interest & Investment Income | 101.00K | 134.00K | 537.00K | 640.00K | ||
| Currency Exchange Gain (Loss) | 71.00K | 54.00K | -163.00K | -65.00K | -18.00K | -9.00K |
| Other Non Operating Income (Expenses) | 12.00K | 49.00K | ||||
| EBT Excluding Unusual Items | -9.94M | -8.83M | -17.50M | -20.58M | -18.14M | -14.19M |
| Impairment of Goodwill | -19.09M | |||||
| Legal Settlements | 2.60M | -1.60M | ||||
| Pretax Income | -9.94M | -8.83M | -17.50M | -17.98M | -38.84M | -14.19M |
| Net Income | -9.94M | -8.83M | -17.50M | -17.98M | -38.84M | -14.19M |
| Net Income to Common | -9.94M | -8.83M | -17.50M | -17.98M | -38.84M | -14.19M |
| Shares Outstanding (Basic) | 13.10M | 11.29M | 10.17M | 9.65M | 8.14M | 7.36M |
| Shares Outstanding (Diluted) | 13.10M | 11.29M | 10.17M | 9.65M | 8.14M | 7.36M |
| EPS (Basic) | -0.76 | -0.78 | -1.72 | -1.86 | -4.77 | -1.93 |
| EPS (Diluted) | -0.76 | -0.78 | -1.72 | -1.86 | -4.77 | -1.93 |
| Free Cash Flow | -7.97M | -8.20M | -16.49M | -14.78M | -21.51M | -12.77M |
| Free Cash Flow Per Share | -0.61 | -0.73 | -1.62 | -1.53 | -2.64 | -1.73 |
| Operating Margin | -3,063.64% | |||||
| Profit Margin | -3,011.51% | |||||
| Free Cash Flow Margin | -2,413.94% | |||||
| EBITDA | -10.06M | -8.95M | -17.75M | -20.97M | -17.95M | -14.03M |
| D&A For EBITDA | 50.00K | 72.00K | 126.00K | 189.00K | 185.00K | 190.00K |
| EBIT | -10.11M | -9.02M | -17.88M | -21.16M | -18.14M | -14.22M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 2.17M | 7.03M | 9.86M | 26.35M | 37.14M | 58.70M |
| Cash & Short-Term Investments | 2.17M | 7.03M | 9.86M | 26.35M | 37.14M | 58.70M |
| Other Receivables | 736.00K | 706.00K | 1.22M | 890.00K | 716.00K | |
| Receivables | 736.00K | 706.00K | 1.22M | 890.00K | 716.00K | |
| Prepaid Expenses | 256.00K | 328.00K | 430.00K | 1.77M | 543.00K | 568.00K |
| Restricted Cash | 75.00K | 75.00K | 75.00K | 75.00K | 75.00K | 50.00K |
| Other Current Assets | 1.70M | |||||
| Total Current Assets | 3.24M | 8.13M | 11.58M | 29.09M | 40.18M | 59.32M |
| Property, Plant & Equipment | 1.30M | 1.48M | 1.85M | 2.12M | 616.00K | 931.00K |
| Goodwill | 19.09M | |||||
| Other Long-Term Assets | 114.00K | 95.00K | 29.00K | 46.00K | 46.00K | 46.00K |
| Total Assets | 4.65M | 9.71M | 13.46M | 31.26M | 40.84M | 79.39M |
| Accounts Payable | 1.89M | 890.00K | 1.54M | 1.22M | 614.00K | 578.00K |
| Accrued Expenses | 372.00K | 986.00K | 585.00K | 1.80M | 362.00K | 719.00K |
| Current Portion of Leases | 352.00K | 334.00K | 301.00K | 240.00K | 240.00K | 236.00K |
| Other Current Liabilities | 12.00K | |||||
| Total Current Liabilities | 2.62M | 2.21M | 2.43M | 3.26M | 1.22M | 1.54M |
| Long-Term Leases | 989.00K | 1.17M | 1.50M | 1.61M | 57.00K | 298.00K |
| Total Liabilities | 3.60M | 3.38M | 3.93M | 4.88M | 1.27M | 1.84M |
| Common Stock | 13.00K | 13.00K | 10.00K | 10.00K | 8.00K | 8.00K |
| Additional Paid-In Capital | 348.74M | 348.57M | 342.93M | 342.29M | 337.49M | 336.63M |
| Retained Earnings | -347.71M | -342.25M | -333.42M | -315.91M | -297.93M | -259.09M |
| Shareholders' Equity | 1.04M | 6.33M | 9.52M | 26.38M | 39.57M | 77.55M |
| Total Liabilities & Equity | 4.65M | 9.71M | 13.46M | 31.26M | 40.84M | 79.39M |
| Total Debt | 1.34M | 1.50M | 1.81M | 1.85M | 297.00K | 534.00K |
| Net Cash (Debt) | 828.00K | 5.52M | 8.05M | 24.50M | 36.85M | 58.17M |
| Net Cash Per Share | 0.06 | 0.49 | 0.79 | 2.54 | 4.52 | 7.90 |
| Filing Date Shares Outstanding | 19.26M | 13.79M | 10.17M | 10.17M | 8.14M | 8.12M |
| Total Common Shares Outstanding | 13.79M | 13.78M | 10.17M | 10.17M | 8.14M | 8.12M |
| Working Capital | 620.00K | 5.92M | 9.15M | 25.83M | 38.96M | 57.78M |
| Book Value Per Share | 0.08 | 0.46 | 0.94 | 2.59 | 4.86 | 9.55 |
| Tangible Book Value | 1.04M | 6.33M | 9.52M | 26.38M | 39.57M | 58.46M |
| Tangible Book Value Per Share | 0.08 | 0.46 | 0.94 | 2.59 | 4.86 | 7.20 |
| Machinery | 1.93M | 1.93M | 1.92M | 1.91M | 1.76M | 1.69M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -9.94M | -8.83M | -17.50M | -17.98M | -38.84M | -14.19M |
| Depreciation & Amortization | 50.00K | 72.00K | 126.00K | 189.00K | 185.00K | 382.00K |
| Asset Writedown & Restructuring Costs | 19.09M | |||||
| Stock-Based Compensation | 280.00K | 270.00K | 643.00K | 801.00K | 855.00K | 724.00K |
| Other Operating Activities | 3.00K | 3.00K | 110.00K | -14.00K | -18.00K | -244.00K |
| Change in Accounts Receivable | -35.00K | 556.00K | ||||
| Change in Accounts Payable | 750.00K | -251.00K | -895.00K | 2.05M | -321.00K | 217.00K |
| Change in Other Net Operating Assets | -7.00K | 36.00K | 1.36M | 470.00K | -1.68M | -169.00K |
| Operating Cash Flow | -7.95M | -8.19M | -16.48M | -14.67M | -21.43M | -12.72M |
| Capital Expenditures | -12.00K | -12.00K | -8.00K | -118.00K | -74.00K | -52.00K |
| Investing Cash Flow | -12.00K | -12.00K | -8.00K | -118.00K | -74.00K | -52.00K |
| Long-Term Debt Repaid | -7.00K | -27.00K | -39.00K | |||
| Net Debt Issued (Repaid) | -7.00K | -27.00K | -39.00K | |||
| Issuance of Common Stock | 5.37M | 5.37M | 4.00M | 38.51M | ||
| Financing Cash Flow | 5.37M | 5.37M | 3.99M | -27.00K | 38.47M | |
| Net Cash Flow | -2.60M | -2.83M | -16.49M | -10.79M | -21.54M | 25.70M |
| Free Cash Flow | -7.97M | -8.20M | -16.49M | -14.78M | -21.51M | -12.77M |
| Free Cash Flow Margin | -2,413.94% | |||||
| Free Cash Flow Per Share | -0.61 | -0.73 | -1.62 | -1.53 | -2.64 | -1.73 |
| Levered Free Cash Flow | -4.32M | -4.95M | -10.29M | -10.01M | -13.12M | -7.28M |
| Unlevered Free Cash Flow | -4.32M | -4.95M | -10.29M | -10.01M | -13.12M | -7.28M |
| Change in Working Capital | 1.65M | 294.00K | 140.00K | 2.34M | -2.71M | 604.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 20.32M | 13.49M | 20.55M | 17.52M | 15.88M | 63.35M |
| Enterprise Value | 19.49M | 7.35M | 9.41M | -12.10M | -25.82M | 2.30M |
| Last Close Price | 0.99 | 0.98 | 2.02 | 1.72 | 1.95 | 7.80 |
| PB Ratio | 13.14 | 2.13 | 2.16 | 0.66 | 0.40 | 0.82 |
| P/TBV Ratio | 19.37 | 2.13 | 2.16 | 0.66 | 0.40 | 1.08 |
| Debt / Equity Ratio | 1.28 | 0.24 | 0.19 | 0.07 | 0.01 | 0.01 |
| Net Debt / Equity Ratio | -0.79 | -0.87 | -0.85 | -0.93 | -0.93 | -0.75 |
| Net Debt / EBITDA Ratio | 0.08 | 0.62 | 0.45 | 1.17 | 2.05 | 4.15 |
| Net Debt / FCF Ratio | 0.10 | 0.67 | 0.49 | 1.66 | 1.71 | 4.55 |
| Asset Turnover | 0.05 | |||||
| Quick Ratio | 1.11 | 3.50 | 4.56 | 8.35 | 31.14 | 38.00 |
| Current Ratio | 1.24 | 3.68 | 4.77 | 8.92 | 33.04 | 38.40 |
| Return on Equity (ROE) | -311.68% | -111.40% | -97.50% | -54.54% | -66.32% | -21.81% |
| Return on Assets (ROA) | -96.07% | -48.66% | -49.98% | -36.68% | -18.86% | -13.30% |
| Return on Capital Employed (ROCE) | -497.30% | -120.20% | -162.10% | -75.60% | -45.80% | -18.30% |
| Earnings Yield | -71.93% | -65.44% | -85.17% | -102.64% | -244.58% | -22.39% |
| FCF Yield | -39.38% | -60.80% | -80.25% | -84.38% | -135.46% | -20.16% |
| Buyback Yield / Dilution | -28.73% | -10.97% | -5.42% | -18.52% | -10.58% | -60.04% |